Mouse mammary cells were preblocked with 10% normal rat serum and then incubated with the following primary antibodies: CD31-biotin (clone 390, eBioscience), CD45-biotin (clone 30-F11, eBioscience), Ter119-biotin (clone Ter119, eBioscience), BP-1-biotin (clone 6C3, eBioscience), EpCAM-APC (clone G8.8, BioLegend), CD49f-AF488 (clone GoH3, BioLegend), CD49b-PE (HMα2, BioLegend), and Sca1-PE/Cy7 (clone D7, BioLegend). In some experiments, cells were stained with CD24-PE (clone M1/69, BioLegend) and CD29 (clone HMβ1-1, BioLegend). CD45, Ter119, CD31, and BP-1 were used to deplete contaminating hematopoietic, endothelial, and a proportion of stromal cells, respectively (collectively termed Lin + cells). Biotin-conjugated antibodies were detected with Streptavidin-APC-Cy7 (BioLegend). Cells were then filtered through a 30-μm cell strainer and incubated with 4′,6-diamidino-2-phenylindole (DAPI; Invitrogen) and were analyzed by using an LSRII (Becton Dickinson) and were sorted on a FACSAria I (Becton Dickinson). The flow-cytometry gating strategy was as previously described [11 (link)].
Free full text: Click here